Trial
NCT05484167
Natesto Testosterone Nasal Gel for Hypogonadal Men
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
Acerus Pharmaceuticals Corporation
Condition
Erectile Dysfunction
Intervention
Natesto Nasal Product
Why stopped
They study lost funding and decided to close the study down.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-21